The Patent Finder

Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma

Cell Signaling Technology, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2007/001360, filed Jan 19, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,099,188Ros Kinase in Lung Cancer
In force
 · Medium confidence
UsedRemaining
Cell Signaling Technology, Inc.In forceMedium confidence
US 11,761,005Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 9,328,349Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
In force
 · Medium confidence
Cell Signaling Technology, Inc.In forceMedium confidence
US 10,526,661Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
In force
 · Medium confidence
Cell Signaling Technology, Inc.In forceMedium confidence
US 8,383,799Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 9,539,254Mutant ROS Expression In Human Cancer
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 9,364,477Mutant ROS Expression In Human Cancer
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
Application 12/581,126Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
Abandoned
Abandoned Feb 21, 2013
Cell Signaling Technology, Inc.AbandonedAbandoned Feb 21, 2013
Application 13/113,676ROS Kinase in Lung Cancer
Abandoned
Abandoned Jun 7, 2018
Cell Signaling Technology, Inc.AbandonedAbandoned Jun 7, 2018
Application 13/632,673Translocation and Mutant Ros Kinase in Human Non-Small Cell Lung Carcinoma
Abandoned
Abandoned Apr 13, 2016
Cell Signaling Technology, Inc.AbandonedAbandoned Apr 13, 2016
4 more records in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 2 expiring within the 18 months from Nov 19, 2026.
Upgrade to Pro
7 of these are in force and held by Cell Signaling Technology, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited